Vaxcyte Inc. (1PCVX)
MTA
Closed
Oct 2, 2026
Day's Range
51.5052 wk Range
27.80Overview - 1PCVX - Vaxcyte Inc.
Key Statistics
Valuation
Enterprise Value
5.27B
P/E (Trailing)
‪-9.14‬
PEG Ratio
‪-0.14‬
Price / Book
‪2.98‬
EV / EBITDA
‪-5.23‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-22.60%‬
Return on Equity
‪-36.51%‬
Ownership
Shares Outstanding
144.78M
Float
136.43M
Held by Insiders
‪0.49%‬
Held by Institutions
‪113.46%‬
Price stats
Beta
‪1.22‬
50-Day Avg
‪51.05‬
200-Day Avg
‪47.10‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1PCVX - Vaxcyte Inc.
Peers - 1PCVX - Vaxcyte Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1PCVXMTAVaxcyte Inc.5.41BMarket Cap+46.02%52-week change-9.15P/E (Trailing)‪0.00%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated Common Stock107.27BMarket Cap+27.72%52-week change30.40P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals, Inc.73.52BMarket Cap+30.66%52-week change19.47P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals, Inc.45.81BMarket Cap-73.35%52-week change43.84P/E (Trailing)‪16.12%‬Profit Margin
- 1INSMMTAInsmed Incorporated30.28BMarket Cap-19.46%52-week change-16.17P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-40.10%52-week change42.38P/E (Trailing)‪13.01%‬Profit Margin
- 1INCYMTAIncyte Corp.17.89BMarket Cap+32.92%52-week change15.77P/E (Trailing)‪27.70%‬Profit Margin
Profile Summary - 1PCVX - Vaxcyte Inc.
About
Vaxcyte Inc. is a clinical-stage vaccine company focused on developing next-generation vaccines for bacterial infectious diseases. The company uses its proprietary cell-free protein synthesis platform to design and produce optimized protein carriers and antigens, supporting the creation of conjugate and protein-based…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
